Evidence map›Paper›PMID 36609992›Full record

ArticleAddiction (Abingdon, England)2023

Development and evaluation of a risk algorithm predicting alcohol dependence after early onset of regular alcohol use.

Chrianna Bharat, Meyer D Glantz, Sergio Aguilar-Gaxiola, Jordi Alonso, Ronny Bruffaerts, Brendan Bunting, José Miguel Caldas-de-Almeida, Graça Cardoso, Stephanie Chardoul, Peter de Jonge and 21 more

Abstract read
In one paragraph

Article in Addiction (Abingdon, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Table 2 Fallacy in Descriptive Epidemiology: Bringing Machine Learning to the Table.International journal of environmental research and public health · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Chrianna BharatNational Drug and Alcohol Research Centre (NDARC), University of New South Wales Australia, Sydney, NSW, Australia.ORCID 0000-0002-9778-0386
Meyer D GlantzDepartment of Epidemiology, Services, and Prevention Research (DESPR), National Institute on Drug Abuse (NIDA), National Institute of Health (NIH), Bethesda, MA, USA.
Sergio Aguilar-GaxiolaCenter for Reducing Health Disparities, UC Davis Health System, Sacramento, CA, USA.
Jordi AlonsoHealth Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain.
Ronny BruffaertsUniversitair Psychiatrisch Centrum - Katholieke Universiteit Leuven (UPC-KUL), Campus Gasthuisberg, Leuven, Belgium.
Brendan BuntingSchool of Psychology, Ulster University, Londonderry, UK.
José Miguel Caldas-de-AlmeidaLisbon Institute of Global Mental Health and Chronic Diseases Research Center (CEDOC), NOVA Medical School|Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal.
Graça CardosoLisbon Institute of Global Mental Health and Chronic Diseases Research Center (CEDOC), NOVA Medical School|Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal.
Stephanie ChardoulInstitute for Social Research, University of Michigan, Ann Arbor, MI, USA.
Peter de JongeDepartment of Developmental Psychology, University of Groningen, Groningen, The Netherlands.
Oye GurejeDepartment of Psychiatry, University College Hospital, Ibadan, Nigeria.
Josep Maria HaroResearch, Teaching and Innovation Unit, Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, Centre for Biomedical Research on Mental Health (CIBERSAM), Madrid, Spain.
Meredith G HarrisSchool of Public Health, The University of Queensland, Herston, QLD, Australia.
Elie G KaramDepartment of Psychiatry and Clinical Psychology, Faculty of Medicine, Institute for Development, Research, Advocacy and Applied Care (IDRAAC), St George Hospital University Medical Center, Balamand University, Beirut, Lebanon.
Norito KawakamiDepartment of Mental Health, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Andrzej KiejnaInstitute of Psychology, University of Lower Silesia, Wroclaw, Poland.
Viviane Kovess-MasfetyEcole des Hautes Etudes en Santé Publique (EHESP), Paris Descartes University, Paris, France.
Sing LeeDepartment of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong.
John J McGrathQueensland Centre for Mental Health Research, The Park Centre for Mental Health, Wacol, QLD, Australia.ORCID 0000-0002-4792-6068
Jacek MoskalewiczInstitute of Psychiatry and Neurology, Warsaw, Poland.
Fernando Navarro-MateuInstituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.ORCID 0000-0002-3228-623X
Charlene RapseyDepartment of Psychological Medicine, University of Otago, Dunedin, New Zealand.
Nancy A SampsonDepartment of Health Care Policy, Harvard Medical School, Boston, MA, USA.
Kate M ScottDepartment of Psychological Medicine, University of Otago, Dunedin, New Zealand.
Hisateru TachimoriDepartment of Clinical Data Science, Clinical Research and Education Promotion Division, National Center of Neurology and Psychiatry, Endowed Course for Health System Innovation, Keio University School of Medicine, Tokyo, Japan.
Margreet Ten HaveTrimbos-Instituut, Netherlands Institute of Mental Health and Addiction, Utrecht, the Netherlands.
Gemma VilagutHealth Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain.
Bogdan WojtyniakCentre of Monitoring and Analyses of Population Health, National Institute of Public Health-National Research Institute, Warsaw, Poland.
Miguel XavierLisbon Institute of Global Mental Health and Chronic Diseases Research Center (CEDOC), NOVA Medical School|Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal.
Ronald C KesslerDepartment of Health Care Policy, Harvard Medical School, Boston, MA, USA.
Louisa DegenhardtNational Drug and Alcohol Research Centre (NDARC), University of New South Wales Australia, Sydney, NSW, Australia.ORCID 0000-0002-8513-2218

Funding

EPIDEMIOLOGY-- NATIONAL COMORBIDITY SURVEY REPLICATIONU01MH060220 · NIMH · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI KESSLER, RONALD C · 1999 to 2010
$18.7M
Risk Factors for Psychopathology in the WHO WMH SurveysR01MH070884 · NIMH · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI KESSLER, RONALD C · 2005 to 2009
$6.0M
Social Role Disability and Mental-Physical Co-MorbidityR01MH069864 · NIMH · KAISER FOUNDATION HEALTH PLAN OF WASHINGTON · PI VON KORFF, MICHAEL R · 2004 to 2007
$2.2M
CROSS-NATIONAL STUDIES OF DRUG INVOLVEMENT: WMH2000R01DA016558 · NIDA · MICHIGAN STATE UNIVERSITY · PI ANTHONY, JAMES CHRISTOPHER · 2003 to 2008
$1.7M
World Mental Health Consortium Annual Meeting 2003-07R13MH066849 · NIMH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HEERINGA, STEVEN G · 2003 to 2007
$735k
Lebanon-Epidemiology: The NCS Replication StudyR03TW006481 · FIC · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI KESSLER, RONALD C · 2004 to 2006
$142k
FIC NIH HHS R03 TW006481NIDA NIH HHS R01 DA016558NIMH NIH HHS R01 MH069864NIMH NIH HHS R01 MH070884NIMH NIH HHS R13 MH066849NIMH NIH HHS U01 MH060220
6 · The paper itself

Abstract

aimsLikelihood of alcohol dependence (AD) is increased among people who transition to greater levels of alcohol involvement at a younger age. Indicated interventions delivered early may be effective in reducing risk, but could be costly. One way to increase cost-effectiveness would be to develop a prediction model that targeted interventions to the subset of youth with early alcohol use who are at highest risk of subsequent AD.

designA prediction model was developed for DSM-IV AD onset by age 25 years using an ensemble machine-learning algorithm known as 'Super Learner'. Shapley additive explanations (SHAP) assessed variable importance. SETTING AND

participantsRespondents reporting early onset of regular alcohol use (i.e. by 17 years of age) who were aged 25 years or older at interview from 14 representative community surveys conducted in 13 countries as part of WHO's World Mental Health Surveys. MEASUREMENTS: The primary outcome to be predicted was onset of life-time DSM-IV AD by age 25 as measured using the Composite International Diagnostic Interview, a fully structured diagnostic interview.

findingsAD prevalence by age 25 was 5.1% among the 10 687 individuals who reported drinking alcohol regularly by age 17. The prediction model achieved an external area under the curve [0.78; 95% confidence interval (CI) = 0.74-0.81] higher than any individual candidate risk model (0.73-0.77) and an area under the precision-recall curve of 0.22. Overall calibration was good [integrated calibration index (ICI) = 1.05%]; however, miscalibration was observed at the extreme ends of the distribution of predicted probabilities. Interventions provided to the 20% of people with highest risk would identify 49% of AD cases and require treating four people without AD to reach one with AD. Important predictors of increased risk included younger onset of alcohol use, males, higher cohort alcohol use and more mental disorders.

conclusionsA risk algorithm can be created using data collected at the onset of regular alcohol use to target youth at highest risk of alcohol dependence by early adulthood. Important considerations remain for advancing the development and practical implementation of such models.

Indexed as

AlcoholismAdolescentAdultAlcohol DrinkingEthanolHumansMalePrevalenceSurveys and QuestionnairesEthanolAdolescencealcohol usecalibrationdependencediscriminationmachine learning

Identifiers

PMID36609992
PMCPMC10073308

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.